Maybe Pfizer will reach its goal of 4 billion savings by the end of this year. Restructuring has been actually massive, with significant changes in development and business goals. I’m afraid there will be more turmoil next year, because there will be further massive adjustments, and god knows if the new direction will pay off. I’ve liked working at Pfizer, but I’ve started looking for other opportunities.
There are no replies in this thread yet. Be the first to post a reply below: